Cancer Family
Malignant Digestive System Neoplasm
CI-CAN-00000229Explore in graph →
4,262 active trials43 approved drugs556 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000229Explore in graph →
Clinical trials
19,101 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (2,000)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00960284 | Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer(PACT-7) | completed | Phase 2 / Phase 3 | 102 | IRCCS San RaffaeleOTHER | 1 | Jan 13, 2012 | clinicaltrials |
| NCT00313872 | Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer | completed | Phase 3 | 200 | Samsung Medical CenterOTHER | 1 | Jan 12, 2012 |
| NCT00911391 | Randomised Trial of Doppler-Optimised Fluid Balance in Elective Colectomy | completed | Phase 3 | 85 | University of Auckland, New ZealandOTHER | 1 | Nov 29, 2011 | clinicaltrials |
| NCT00323830 | Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric Adenocarcinoma | completed | Phase 3 | 458 | Samsung Medical CenterOTHER | 1 | Nov 9, 2011 | clinicaltrials |
| NCT00665197 | Palliative Radiotherapy and Brachytherapy for Oesophageal Cancer Dysphagia | completed | Phase 3 | 200 | International Atomic Energy AgencyOTHER_GOV | 7 | Oct 13, 2011 | clinicaltrials |
| NCT00374036 | Metastatic Gastric Cancer FFCD 03-07 | completed | Phase 3 | 416 | University Hospital, ToulouseOTHER | 1 | Oct 12, 2011 | clinicaltrials |
| NCT00058149 | Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 3 | — | Eastern Cooperative Oncology GroupNETWORK | 2 | Sep 21, 2011 | clinicaltrials |
| NCT00870558 | Iodine I 131 Ethiodized Oil in Preventing Recurrent Cancer in Patients Who Have Undergone Treatment for Liver Cancer | completed | Phase 3 | 120 | Hospices Civils de LyonOTHER | 1 | Aug 16, 2011 | clinicaltrials |
| NCT00606983 | Prevention of Acute Voiding Difficulty After Radical Proctectomy | completed | Phase 3 | 100 | Seoul National University HospitalOTHER | 1 | Jul 20, 2011 | clinicaltrials |
| NCT00970138 | Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer | completed | Phase 2 / Phase 3 | 141 | Fudan UniversityOTHER | 1 | Jul 12, 2011 | clinicaltrials |
| NCT00150670 | Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancer | completed | Phase 3 | 300 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00152217 | Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC) | completed | Phase 3 | 1,000 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00152230 | A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC) | completed | Phase 3 | 900 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00152243 | A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC) | completed | Phase 3 | 500 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00202969 | Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer | completed | Phase 3 | 180 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00287768 | Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer | completed | Phase 3 | 628 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00639327 | Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer | completed | Phase 2 / Phase 3 | 300 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00145314 | FLOX in Combination With Cetuximab in First-line Treatment of Colorectal Cancer | completed | Phase 3 | 571 | The Nordic Colorectal Cancer Biomodulation GroupOTHER | 1 | Jan 14, 2011 | clinicaltrials |
| NCT00192712 | Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic Cancer | completed | Phase 2 / Phase 3 | 20 | Rambam Health Care CampusOTHER | 1 | Nov 10, 2010 | clinicaltrials |
| NCT00230646 | Promoting Physical Activity After Colorectal Cancer | completed | Phase 3 | 46 | The Miriam HospitalOTHER | 1 | Oct 5, 2010 | clinicaltrials |
| NCT00471965 | Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma Patients(EACH) | completed | Phase 3 | 371 | SanofiINDUSTRY | 4 | Sep 20, 2010 | clinicaltrials |
| NCT01186081 | Comparison of Preoperative and Postoperative Radiotherapy and Capecitabine in Locally Advanced Rectal Cancer | completed | Phase 3 | 240 | Asan Medical CenterOTHER | 1 | Aug 23, 2010 | clinicaltrials |
| NCT00469443 | Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC | completed | Phase 3 | 330 | Hellenic Oncology Research GroupOTHER | 1 | Aug 19, 2010 | clinicaltrials |
| NCT00606619 | Effects of Early Oral Feeding After Resection of Gastric Cancer | completed | Phase 3 | 58 | The Catholic University of KoreaOTHER | 1 | May 28, 2010 | clinicaltrials |
| NCT00061815 | Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer | completed | Phase 3 | 102 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 12, 2010 | clinicaltrials |
| NCT00063141 | Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer | completed | Phase 3 | 1,302 | Eli Lilly and CompanyINDUSTRY | 17 | Apr 12, 2010 | clinicaltrials |
| NCT00425152 | Fluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Colon Cancer | completed | Phase 3 | 2,151 | NSABP Foundation IncNETWORK | 0 | Feb 8, 2010 | clinicaltrials |
| NCT01060501 | Modulation of Adjuvant 5-FU by Folinic Acid and Interferon-alpha in Colon Cancer(FOGT1) | completed | Phase 3 | 796 | University of UlmOTHER | 1 | Feb 2, 2010 | clinicaltrials |
| NCT00378716 | Combination Chemotherapy in Treating Patients With Resected Colon Cancer | completed | Phase 3 | 1,608 | NSABP Foundation IncNETWORK | 0 | Jan 11, 2010 | clinicaltrials |
| NCT01032967 | Surgery or Chemoradiation for Esophageal Cancer | completed | Phase 3 | 40 | Chinese University of Hong KongOTHER | 0 | Dec 16, 2009 | clinicaltrials |
| NCT00467922 | An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy | completed | Phase 3 | 69 | Corewell Health WestOTHER | 1 | Oct 21, 2009 | clinicaltrials |
| NCT00495846 | GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma(SS-HCC) | completed | Phase 2 / Phase 3 | 25 | Federico II UniversityOTHER | 1 | Aug 17, 2009 | clinicaltrials |
| NCT00195572 | Study Evaluating Isovorin in Advanced/Recurrent Gastric Cancer | completed | Phase 3 | 200 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Aug 13, 2009 | clinicaltrials |
| NCT00195585 | Study Evaluating Isovorin in Colon Cancer | completed | Phase 3 | 650 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Aug 13, 2009 | clinicaltrials |
| NCT00894725 | Laparoscopic Versus Open Left Colonic Resection | completed | Phase 3 | 268 | Università Vita-Salute San RaffaeleOTHER | 1 | May 7, 2009 | clinicaltrials |
| NCT00099294 | Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer | completed | Phase 3 | 300 | Threshold PharmaceuticalsINDUSTRY | 11 | Apr 30, 2009 | clinicaltrials |
| NCT00485316 | Laparoscopic Assisted Versus Open Resection for Colorectal Carcinoma | completed | Phase 3 | — | Chinese University of Hong KongOTHER | 1 | Mar 31, 2009 | clinicaltrials |
| NCT00738478 | Quality of Life After Routine Nasogastric Decompression After Distal Gastrectomy for Gastric Cancer Patients | completed | Phase 3 | 180 | Wakayama Medical UniversityOTHER | 1 | Feb 18, 2009 | clinicaltrials |
| NCT00149201 | A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis | completed | Phase 3 | 160 | Japan Clinical Oncology GroupOTHER | 1 | Feb 3, 2009 | clinicaltrials |
| NCT00312000 | Sequential Versus Combination Chemotherapy in Advanced Colorectal Carcinoma | completed | Phase 3 | 820 | Dutch Colorectal Cancer GroupOTHER | 0 | Sep 8, 2008 | clinicaltrials |
| NCT00746161 | Evaluation of Double Tract Reconstruction After Total Gastrectomy in Patients With Gastric Cancer | completed | Phase 3 | 44 | Wakayama Medical UniversityOTHER | 1 | Sep 4, 2008 | clinicaltrials |
| NCT00652587 | Hepatectomy With or Without Transcatheter Arterial Chemoembolization for Stage IIIA Hepatocellular Carcinoma | completed | Phase 3 | 115 | Sun Yat-sen UniversityOTHER | 1 | Apr 3, 2008 | clinicaltrials |
| NCT00644618 | Randomized Controlled Trial of Gemcitabine Combined With 125I Brachytherapy | completed | Phase 3 | 120 | Huazhong University of Science and TechnologyOTHER | 0 | Mar 27, 2008 | clinicaltrials |
| NCT00040092 | A Study to Test the Effectiveness of Virulizin® Given in Combination With Standard Chemotherapy for Pancreatic Cancer | completed | Phase 3 | 400 | Aptose Biosciences Inc.INDUSTRY | 0 | Jan 7, 2008 | clinicaltrials |
| NCT00234429 | A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma | completed | Phase 2 / Phase 3 | 74 | AstraZenecaINDUSTRY | 1 | Dec 18, 2007 | clinicaltrials |
| NCT00529412 | Bioresorbable Membrane to Reduce Postoperative Small Bowel Obstruction | completed | Phase 3 | 150 | Nihon UniversityOTHER | 1 | Sep 14, 2007 | clinicaltrials |
| NCT00294359 | The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer | completed | Phase 2 / Phase 3 | 333 | Australasian Gastro-Intestinal Trials GroupNETWORK | 2 | Aug 22, 2007 | clinicaltrials |
| NCT00386984 | Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma | completed | Phase 3 | 108 | University Hospital FreiburgOTHER | 1 | Oct 12, 2006 | clinicaltrials |
| NCT00272051 | XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy | completed | Phase 3 | 620 | SanofiINDUSTRY | 0 | Sep 13, 2006 | clinicaltrials |
| NCT00309530 | Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C | completed | Phase 3 | 598 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Apr 3, 2006 | clinicaltrials |
Data updated 23 days agoSource updated Jan 13, 2012source: clinicaltrials